SLC35E4, also referred to as the solute carrier family 35 member E4, is a protein encoded by the SLC35E4 gene in humans. This protein is part of the larger SLC35 family, which is known for its role in the transport of nucleotide sugars. Nucleotide sugar transporters are integral to the process of glycosylation, which is the enzymatic addition of sugar moieties to proteins and lipids, a key post-translational modification critical for proper protein folding, stability, and cell signaling.SLC35E4 is relatively less characterized compared to some of its family members but is believed to function as a transport protein that facilitates the movement of specific nucleotide sugars across cellular membranes, particularly from the cytoplasm where they are synthesized, into the lumen of the Golgi apparatus or the endoplasmic reticulum where glycosylation reactions occur.
The exact substrates of SLC35E4 and its specific role in glycosylation remain to be fully determined. However, given the established functions of similar SLC35 family members, SLC35E4 is likely to be involved in the transport of a specific subset of nucleotide sugars. This transport activity is vital for the maintenance of glycosylation processes, which are essential for the structural integrity and function of many proteins and lipids. Alterations or defects in the SLC35E4 protein could result in abnormal glycosylation patterns, which are known to be associated with a range of disorders, including congenital disorders of glycosylation, which are a group of inherited metabolic conditions that affect multiple systems in the body.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylyl cyclase, potentially influencing membrane transport mechanisms relevant to SLC35E4. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
A Na⁺/K⁺-ATPase inhibitor, which might indirectly affect transport processes related to SLC35E4. | ||||||
12β-Hydroxydigitoxin | 20830-75-5 | sc-213604 sc-213604A | 1 g 5 g | $143.00 $694.00 | ||
Another Na⁺/K⁺-ATPase inhibitor, could indirectly modulate cellular transport mechanisms involving SLC35E4. | ||||||
Amiloride • HCl | 2016-88-8 | sc-3578 sc-3578A | 25 mg 100 mg | $22.00 $57.00 | 6 | |
A diuretic that inhibits sodium channels, potentially affecting sodium transport processes relevant to SLC35E4. | ||||||
Furosemide | 54-31-9 | sc-203961 | 50 mg | $41.00 | ||
A loop diuretic, affects ion transport and could indirectly impact mechanisms involving SLC35E4. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
A calcium channel blocker, might influence calcium transport and indirectly affect SLC35E4-related pathways. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Another calcium channel blocker, potentially affecting transport mechanisms related to SLC35E4. | ||||||
Probenecid | 57-66-9 | sc-202773 sc-202773A sc-202773B sc-202773C | 1 g 5 g 25 g 100 g | $28.00 $39.00 $100.00 $277.00 | 28 | |
Inhibits organic anion transporters and could indirectly affect transport processes related to SLC35E4. | ||||||
Cimetidine | 51481-61-9 | sc-202996 sc-202996A | 5 g 10 g | $62.00 $86.00 | 1 | |
Inhibits certain drug transporters, potentially impacting transport pathways involving SLC35E4. | ||||||
Quinidine | 56-54-2 | sc-212614 | 10 g | $104.00 | 3 | |
Affects multiple ion channels and transporters, potentially influencing pathways related to SLC35E4. | ||||||